Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development

Go back to Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
(NASDAQ: OVID) Delayed: 2.40 +0.02 (0.84%)
Previous Close $2.38    52 Week High
Open $2.36    52 Week Low
Day High $2.43    P/E N/A 
Day Low $2.29    EPS
Volume 4,728,434